Stages of Biosynthesis
The formation of iodothyronines is a complex, multi-step cascade of reactions occurring directly within the thyroid tissue.
- Iodide trapping. The first step involves the active transport of iodide from the bloodstream into thyroid follicular cells (thyrocytes). This process is mediated by a sodium-iodide symporter (NIS) alongside sodium (Na+) ions.
- Oxidation and iodination. The enzyme thyroid peroxidase (TPO) oxidizes the incoming iodide. Next, iodination of tyrosine amino acid residues within the thyroglobulin protein structure takes place. This yields precursors: monoiodotyrosine (MIT) and diiodotyrosine (DIT).
- Coupling. MIT and DIT molecules couple with one another, forming the functional hormones T3 and T4, which remain bound to thyroglobulin.
- Secretion. Colloid is engulfed by cells via endocytosis. Proteolysis of thyroglobulin occurs within lysosomes, after which free T3 and T4 molecules are released into the bloodstream.
Regulation of Secretion
The production of iodothyronines is strictly controlled by the hierarchical Hypothalamic-Pituitary-Thyroid (HPT) axis and operates via a negative feedback mechanism.
- Stimulatory pathway: The hypothalamus secretes thyrotropin-releasing hormone (TRH). This peptide acts on the anterior pituitary, stimulating the release of thyroid-stimulating hormone (TSH). In turn, TSH directly stimulates the thyroid gland to synthesize and release T3 and T4.
- Inhibitory pathway: When the blood concentration of iodothyronines becomes elevated, they suppress the higher centers. Excess T3 and T4 inhibit the production of both TSH in the pituitary and TRH in the hypothalamus, preventing excessive stimulation of the gland.
Physiological Effects
Due to their chemical nature, iodothyronines are highly lipophilic. This property allows them to easily cross cell membranes. Their receptors have an intracellular (nuclear) localization. By binding to these receptors, the hormones directly influence gene transcription.
Key physiological effects:
- Energy metabolism: Hormones stimulate Na+,K+-ATPase activity, predictably leading to increased cellular oxygen consumption and an elevated basal metabolic rate.
- Thermoregulation: Iodothyronines ensure an adequate adaptive response to cold exposure by significantly increasing heat production.
- High-dose effects: Excess hormone levels lead to the uncoupling of oxidative phosphorylation. Additionally, the catabolism (breakdown) of proteins and lipids is accelerated.
Clinical Manifestations of Pathologies
Thyroid disorders are divided into two opposing states, each with a specific pathogenesis and symptomatology.
Hypothyroidism (hormone deficiency):
- In adults, the severe form is called myxedema. Proteoglycans (glycosaminoglycans) and water accumulate in the connective tissue, causing characteristic non-pitting mucosal edema of the skin. Symptoms include a decreased basal metabolic rate, cold intolerance, weight gain, bradycardia, and lethargy.
- If hypofunction occurs in early childhood, cretinism develops. It leads to irreversible intellectual and physical developmental delays, as well as impaired bone ossification.
Hyperthyroidism / Thyrotoxicosis (hormone excess):
- A classic example is Graves' disease. This is an autoimmune pathology characterized by the production of thyroid-stimulating immunoglobulins. These antibodies bind to TSH receptors, mimicking TSH action and causing uncontrolled hyperproduction of iodothyronines.
- Manifestations include an elevated basal metabolic rate, rapid weight loss, heat intolerance, tachycardia, tremor, and hyperexcitability.
Monitoring Therapy
In the treatment of hypothyroidism with thyroxine (L-T4) preparations, the serum TSH level is the most crucial criterion for dose adequacy. Due to the negative feedback mechanism, exogenous hormone intake should suppress TSH secretion to normal values. If TSH remains high, the dose is insufficient; if it drops below normal, it indicates an overdose.